Unexplained weight loss, medically termed as 'involuntary weight loss' (IWL), is a common yet perplexing clinical scenario that often poses significant diagnostic challenges. It is defined as a loss of more than 5% of body weight over a period of 6 to 12 months without an apparent cause. This article aims to provide a comprehensive approach to evaluating unexplained weight loss in clinical practice.
The initial assessment should involve a thorough history and physical examination, focusing on dietary intake, physical activity, psychological status, and medication use. The presence of associated symptoms such as anorexia, dysphagia, or gastrointestinal symptoms may provide clues to the underlying cause.
Basic laboratory investigations should include a complete blood count, basic metabolic panel, liver function tests, thyroid function tests, and inflammatory markers. If initial tests are unremarkable, further investigations such as endoscopy, imaging studies, or specialized blood tests may be warranted based on clinical suspicion.
Imaging studies play a crucial role in evaluating unexplained weight loss. Abdominal ultrasound, CT scan, or MRI may be used to identify potential malignancies, chronic infections, or metabolic disorders. PET scan may be considered in patients with high suspicion of malignancy but negative initial workup.
The management of unexplained weight loss is directed at the underlying cause. In cases where no cause is identified, a symptom-focused approach may be adopted, including nutritional support and psychological intervention.
In conclusion, unexplained weight loss is a complex clinical entity requiring a systematic and comprehensive approach for evaluation. The aim should be to identify treatable causes and to provide supportive care in cases where no underlying cause can be found. Further research is needed to develop more effective diagnostic algorithms and management strategies for this challenging clinical scenario.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation